NEW DELHI: Imaging Endpoints, an oncology-focused imaging contract research organization (CRO), has appointed Srikanth Ayyappan as Associate Vice President, Global Marketing. In his new role, Ayyappan will take comprehensive charge of the company’s international marketing strategy across key global markets.
His responsibilities will focus on driving strategic initiatives designed to enhance the corporate brand’s visibility and deepen commercial engagement with clinical sponsors, research partners, and biotechnology stakeholders worldwide.
Driving Precision Oncology Solutions
Ayyappan’s appointment arrives at a critical juncture for the life sciences sector, as advanced imaging technologies increasingly intersect with data science to accelerate clinical trials. Imaging Endpoints specialized solutions play an essential role in backing oncology drug development pipelines.
“Clinical research is entering a transformative phase driven by advances in imaging, data science and precision medicine,” Ayyappan remarked regarding his new appointment. “Imaging Endpoints plays a critical role in supporting oncology drug development through innovative imaging solutions, and I look forward to contributing to the company’s continued growth, global visibility and impact across the life sciences ecosystem.”
About Imaging Endpoints
Operating as a specialized Contract Research Organization (CRO), Imaging Endpoints connects advanced clinical imagery with rigorous scientific data to support complex oncology trials. The integration of Ayyappan into the global leadership suite is aligned with the company’s broader expansion strategy to scale up its service footprint and consolidate its market presence across international pharmaceutical networks.
